Does Priority Health Cover Metformin?

How Priority Health Lists Metformin on Its Formulary

Generic metformin hydrochloride appears on Priority Health's preferred drug list as a Tier 1 medication across commercial HMO, POS, and PPO products. Tier 1 carries the lowest cost-sharing, and for metformin specifically, no prior authorization, step therapy, or quantity edits apply to standard diabetes dosing.

Priority Health, headquartered in Grand Rapids, Michigan, serves roughly 1.1 million members across the state. The insurer updates its formulary at least quarterly, and metformin has remained on Tier 1 without interruption for over a decade. This is consistent with every major U.S. insurer: the American Diabetes Association (ADA) Standards of Care recommend metformin as first-line pharmacotherapy for type 2 diabetes, and insurers are required under the Affordable Care Act's essential health benefits to cover at least one drug in every USP therapeutic category. Metformin, as the sole biguanide, always qualifies.

Extended-release (ER) formulations deserve a closer look. Generic metformin ER 500 mg and 750 mg tablets (the osmotic-release oral system, or "OROS" formulation) sit on Tier 1 at Priority Health. The branded ER product Glumetza, by contrast, lands on Tier 3 (non-preferred brand) or is excluded entirely from some plans. If your pharmacy dispenses a branded ER version, ask for a generic substitution to keep costs at Tier 1 levels.

What You Will Actually Pay Out of Pocket

The dollar amount depends on your specific plan design, but Priority Health's most common commercial copay structures put Tier 1 generics at $5 to $15 for a 30-day retail fill and $10 to $30 for a 90-day mail-order fill. Some Priority Health HMO plans in Michigan carry a $0 generic copay after deductible.

For context, metformin is one of the least expensive prescription drugs in the United States. A 2023 analysis published in JAMA Internal Medicine found that the median out-of-pocket cost for metformin across all U.S. insurers was $3.90 per 30-day fill [1]. Priority Health's cost-sharing falls within this range.

Members enrolled in Priority Health's high-deductible health plans (HDHPs) paired with a health savings account (HSA) should note that metformin for diabetes is classified as preventive under IRS Notice 2019-45. This means the plan can cover metformin at $0 before the deductible is met, and most Priority Health HDHP designs do exactly that [2]. If your pharmacy is charging you full price on an HDHP, call the number on your Priority Health ID card: the preventive drug benefit may not have been applied correctly.

Priority Health Medicare Advantage and Medicaid Plans

Priority Health operates several Medicare Advantage plans in Michigan (branded as Priority Health Medicare) and a Medicaid managed care plan called Priority Health Choice. Coverage details differ from commercial products.

On Medicare Advantage Part D plans, metformin falls under the Tier 1 preferred generic category. Many Priority Health Medicare plans offer $0 copays for Tier 1 drugs during the initial coverage phase. After the initial coverage limit ($5,030 in total drug costs for 2025), the Inflation Reduction Act caps insulin copays at $35 and, beginning in 2025, total out-of-pocket Part D spending at $2,000 per year [3]. Metformin costs count toward that cap but rarely push a member close to it on their own.

On Priority Health Choice (Medicaid), generic metformin is covered with a $0 to $3 copay. Michigan Medicaid does not require prior authorization for metformin when prescribed for type 2 diabetes, prediabetes, gestational diabetes, or polycystic ovary syndrome (PCOS).

Metformin for Longevity and Off-Label Use: Will Priority Health Pay?

This is where coverage gets complicated. Metformin is FDA-approved only for type 2 diabetes. Prescribers increasingly use it off-label for prediabetes prevention, PCOS, and, in longevity medicine circles, as a potential geroprotective agent based on observational data and the ongoing TAME (Targeting Aging with Metformin) trial [4].

Priority Health, like most insurers, adjudicates claims based on the ICD-10 diagnosis code attached to the prescription. A metformin claim coded as E11.x (type 2 diabetes) or E13.x (other specified diabetes) will process without issue. A claim coded as R73.03 (prediabetes) will also typically process, since the ADA and the Diabetes Prevention Program (DPP) trial support metformin for diabetes prevention in high-risk adults with BMI ≥35, age <60, or history of gestational diabetes [5].

A claim coded for "anti-aging" or a Z-code (such as Z76.89, "persons encountering health services in other specified circumstances") may be denied. Priority Health's commercial plans do not list longevity or aging as a covered indication. If your clinician prescribes metformin primarily for its potential geroprotective effects, the most reliable path to coverage is a legitimate co-existing diagnosis, whether that is prediabetes (fasting glucose 100 to 125 mg/dL or HbA1c 5.7% to 6.4%), insulin resistance, or PCOS.

Even if coverage is denied, generic metformin costs $4 to $12 per month at cash-pay prices through GoodRx or Cost Plus Drugs, making it one of the rare medications where out-of-pocket payment is genuinely affordable.

How to Verify Your Specific Coverage

Do not rely on general formulary PDFs alone. Priority Health plan designs vary by employer group, and self-funded employers can customize their formularies. Three reliable verification methods exist.

First, log in to the Priority Health member portal at priorityhealth.com. Manage to "Find a Drug" and search for metformin. The tool will display your plan-specific tier, copay, and any utilization management requirements.

Second, call Priority Health's Pharmacy Services line at 800-942-0954. A representative can run a real-time test claim to confirm your copay amount at a specific pharmacy.

Third, ask your pharmacist to run a test adjudication at the point of sale. This takes about 60 seconds and returns the exact copay Priority Health will charge for your specific prescription, dose, and quantity.

Prior Authorization and Step Therapy Scenarios

Standard generic metformin (IR or ER) does not require prior authorization at Priority Health for diabetes-related diagnoses. There are, however, three scenarios where you might encounter a coverage barrier.

Brand-name requests. If a prescriber writes "Glucophage" or "Glumetza" with "dispense as written" (DAW), Priority Health may require the member to try generic metformin first (step therapy) or submit a prior authorization explaining why the brand is medically necessary. Medical necessity reasons accepted by most insurers include documented adverse reactions to all available generic formulations or an allergy to a specific inactive ingredient in the generic tablet.

Metformin oral solution. The liquid formulation (Riomet) is significantly more expensive ($200 to $400 per month) and typically sits on Tier 3 or requires prior authorization. It is occasionally needed for patients who cannot swallow tablets.

Combination products. Fixed-dose combinations such as metformin/glipizide, metformin/sitagliptin (Janumet), or metformin/empagliflozin (Synjardy) may fall on Tier 2 or Tier 3 and could require prior authorization or step therapy through metformin monotherapy first.

The Clinical Evidence Behind Metformin Coverage Decisions

Insurers do not cover metformin out of generosity. They cover it because the clinical evidence for cost-effectiveness is overwhelming, and because federal and state regulations essentially mandate it.

The United Kingdom Prospective Diabetes Study (UKPDS) demonstrated that metformin reduced all-cause mortality by 36% and diabetes-related death by 42% in overweight patients with type 2 diabetes compared with conventional dietary therapy alone [6]. No other oral diabetes drug had shown a mortality benefit at the time of publication in 1998, and few have matched it since.

The Diabetes Prevention Program (DPP) randomized 3,234 adults with prediabetes to metformin 850 mg twice daily, intensive lifestyle intervention, or placebo. At a mean follow-up of 2.8 years, metformin reduced the incidence of type 2 diabetes by 31% compared with placebo (7.8 vs. 11.0 cases per 100 person-years). The lifestyle arm performed better (58% reduction), but metformin was most effective in participants with BMI ≥35 and age <60 [5].

A 2024 meta-analysis in The Lancet Healthy Longevity pooled 53 observational studies and found that metformin use in patients with type 2 diabetes was associated with a 12% to 17% relative reduction in all-cause mortality compared with other glucose-lowering medications [7]. These data drive the "metformin for longevity" hypothesis, though the TAME trial (expected to enroll 3,000 participants aged 65 to 79 without diabetes) is the first randomized trial specifically designed to test whether metformin slows composite aging endpoints [4].

Dr. Nir Barzilai, principal investigator of the TAME trial, has stated: "We are not trying to find a drug for aging. We are trying to show the FDA that aging can be targeted, and metformin is the tool to demonstrate that." This distinction matters for insurance coverage. Until a trial like TAME produces positive results and the FDA grants a longevity-related indication, insurers including Priority Health will continue to require a disease-specific diagnosis code.

What to Do If Priority Health Denies Your Metformin Claim

Denials for generic metformin are rare but not impossible, particularly for off-label indications or if the claim is coded incorrectly. The appeals process at Priority Health follows Michigan's standard external review framework.

Step one: request the denial letter in writing. Priority Health is required to provide a specific reason for the denial, including the clinical criteria that were not met.

Step two: file an internal appeal within 60 days of the denial. Include a letter of medical necessity from your prescriber, relevant lab results (fasting glucose, HbA1c, fasting insulin), and citations to clinical guidelines such as the ADA Standards of Care or the Endocrine Society's PCOS guidelines [8].

Step three: if the internal appeal is denied, request an external review through the Michigan Department of Insurance and Financial Services (DIFS). An independent review organization will evaluate the claim. Michigan law requires external review decisions within 45 days for non-urgent cases.

For members who need metformin immediately while an appeal is pending, the cash-pay route remains viable. Walmart, Costco, and Meijer pharmacies in Michigan all offer metformin at $4 for a 30-day supply without insurance.

Metformin Dosing, Formulations, and Switching Tips

Understanding which formulation you are taking can prevent unnecessary coverage problems. Generic metformin IR is available in 500 mg, 850 mg, and 1,000 mg tablets. The ADA recommends starting at 500 mg once or twice daily with meals and titrating to a maximum of 2,000 to 2,550 mg per day based on glycemic response and gastrointestinal tolerability [9].

Metformin ER reduces GI side effects (diarrhea, nausea, abdominal cramping) that lead roughly 5% to 10% of patients to discontinue the IR formulation. A 2017 Cochrane review of 13 trials found that ER and IR formulations produced equivalent HbA1c reductions, but ER was associated with fewer GI adverse events (RR 0.77, 95% CI 0.62 to 0.96) [10].

If you are currently taking IR and experiencing GI side effects, ask your prescriber to switch you to ER. Both formulations are Tier 1 at Priority Health, so the copay should not change. Take ER tablets with the evening meal for optimal absorption, and do not crush or split them, as this destroys the extended-release matrix.

The American Geriatrics Society Beers Criteria recommend caution with metformin in adults with eGFR <30 mL/min/1.73 m² and suggest dose reduction when eGFR falls between 30 and 45 [11]. Priority Health does not enforce renal function monitoring as a coverage requirement, but your prescriber should check a basic metabolic panel at least annually.